Plasma exchange in neurology: a long experience of a safe procedure
AMBAR: a multi-mechanism approach for AD
AMBAR: primary results
An introduction to the AMBAR centre, Barcelona
Overview & Learning Objectives
Therapeutic plasma exchange is widely used for the treatment of various neurological, autoimmune and inflammatory conditions.1,2 In this sponsored Symposium, presented at the 7th Congress of the European Academy of Neurology (EAN) on 21st June 2021, four leading experts discuss the latest clinical data on the use of therapeutic plasma exchange in the field of AD.3
After watching this activity, participants should be better able to:
- Discuss the current treatment landscape in Alzheimer’s disease.
- Describe the rationale behind the use of therapeutic plasma exchange in Alzheimer’s disease.
- Review the results of the AMBAR study.
- Costa M, Paez A. Emerging insights into the role of albumin with plasma exchange in Alzheimer's disease management. Transfus Apher Sci. 2021;60:103164.
- Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171–354.
- Boada M, Lopez OL, Olazaran J, et al. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study. Alzheimers Dement. 2020;16:1412–25.